App-delivered Cognitive-behavioral Therapy for Insomnia Among Patients With Musculoskeletal Complaints
CompletedNot applicableNCT05572697
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this randomized clinical trial is to evaluate the effectiveness of app-delivered cognitive-behavioral therapy for insomnia adjunct to inpatient multimodal rehabilitation for individuals with comorbid insomnia and chronic pain, compared with rehabilitation (usual care) only.
Study details
- Official title
- App-delivered Cognitive-behavioral Therapy for Insomnia Among Patients With Comorbid Musculoskeletal Complaints and Insomnia Referred to 4-week Inpatient Multimodal Rehabilitation
- Conditions
- Interventions
- Behavioral: Digital Cognitive-behavioral therapy for insomnia (dCBT-I)
- Behavioral: Usual care
- Sponsor
- Norwegian University of Science and Technology
- Start date
- 2022-10-07
- Primary completion
- 2025-11-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Norway
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Taking part in inpatient rehabilitation due to long-term musculoskeletal complaints * Insomnia Severity Index (ISI) score \>11. Exclusion Criteria: * Not having a smartphone or tablet. * Individuals with work schedules that includes night shifts during the intervention * Pregnancy * Inadequate opportunity to sleep or living circumstances that prevent modification of sleep patterns such as having an infant * Currently receiving psychological treatment for insomnia * Medical history of contraindicating use of CBT-I such as epilepsy, recent cardiac surgery, and an attack phase of multiple sclerosis
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05572697